Orgenesis Inc. (NasdaqCM:ORGS) agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P. on January 31, 2024. In exchange, MM OS Holdings shall receive a royalty of 5% of the net revenue of Octomera?s cell processing services, for the three calendar years 2025-2027
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 USD | -1.40% | -1.42% | -0.14% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-0.14% | 17.03M | |
-2.54% | 186B | |
-1.85% | 107B | |
-4.26% | 67.44B | |
+1.39% | 50.03B | |
+16.82% | 47.81B | |
+4.79% | 41.03B | |
+3.49% | 26.85B | |
+0.65% | 25.82B | |
+16.55% | 24.74B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P.